跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Almycin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Almycin
Approved
STANDARD
Almycin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5cc6dc01168a0847
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5cc6dc01168a0847
Drug Approval Philippines Name
Almycin
Product Name
Almycin
Registration Number
DRP-2237-01
Brand Name
Almycin
Generic Name
Erythromycin (As Ethylsuccinate)
Dosage Form
Powder For Suspension
Dosage Strength
200 mg/5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Eadriex Pharmaceuticals Phils., Inc.
Distributor
Interhealthcare Pharmaceuticals, Inc.
Issuance Date
29 March 2022
Expiry Date
05 April 2027
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5cc6dc01168a0847
Type
Standard
Back to Philippines FDA Approvals